Art

J-GLOBAL ID：200902160053294382   Reference number：94A0080953

3,4-Dihydroxychalcones as Potent 5-Lipoxygenase and Cyclooxygenase Inhibitors.

5-リポキシゲナーゼおよびシクロオキシゲナーゼ阻害薬としての3,4-ジヒドロキシカルコン類

Author (7)： SOGAWA S (Tokushima Bunri Univ., Tokushima, JPN) ,  NIHRO Y (Tokushima Bunri Univ., Tokushima, JPN) ,  UEDA H (Tokushima Bunri Univ., Tokushima, JPN) ,  IZUMI A (Nippon Hypox Lab., Inc., Yamanashi, JPN) ,  MIKI T (Nippon Hypox Lab., Inc., Yamanashi, JPN) ,  MATSUMOTO H (Tokushima Bunri Univ., Tokushima, JPN) ,  SATOH T (Tokushima Bunri Univ., Tokushima, JPN)
Material： Journal of Medicinal Chemistry  (J Med Chem)
Volume： 36  Issue： 24  Page： 3904-3909  Publication year： Nov. 26, 1993 
JST Material Number： D0102A  ISSN： 0022-2623  CODEN： JMCMAR  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： phenolic compound ,...
Semi thesaurus term： HX-0836 ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=94A0080953&from=J-GLOBAL&jstjournalNo=D0102A") }}

JST classification (1)： Basic research of anti-inflammatory drugs  (GW15010T)

Substance index (51)： HX-0836 ,  2'-Hydroxychalcone ,  4'-Hydroxychalcone ,  2',4'-Dihydroxychalcone ,  3,4-Dihydroxychalcone ,  2′-Chloro-3,4-dihydroxychalcone ,  4′-Chloro-3,4-dihydroxychalcone ,  2′,3,4,5′-Tetrahydroxychalcone ,  2′,3,4-Trihydroxy-5′-methylchalcone ,  2',4',6'-Trihydroxychalcone ,  2',4-Dihydroxychalcone ,  2',4,4'-Trihydroxychalcone ,  Chalcononaringenin ,  2′,3,4-Trihydroxychalcone ,  3,3',4-Trihydroxychalcone ,  3,4,4'-Trihydroxychalcone ,  2′,3,4,4′-Tetrahydroxychalcone ,  Eriodictyol chalcone ,  2′,4-Dihydroxy-3-methoxychalcone ,  3-Methoxy-4-hydroxy-4′-chlorochalcone ,  3,4′-Dimethoxy-4-hydroxychalcone ,  2′,3-Dihydroxy-4-methoxychalcone ,  4′-Nitro-3,4-dihydroxychalcone ,  2′-Trifluoromethyl-3,4-dihydroxychalcone ,  3′-Methyl-3,4-dihydroxychalcone ,  3,4-Dihydroxy-4′-methylchalcone ,  2′-Methoxy-3,4-dihydroxychalcone ,  3′-Methoxy-3,4-dihydroxychalcone ,  4′-Methoxy-3,4-dihydroxychalcone ,  3′-(Dimethylamino)-3,4-dihydroxychalcone ,  4′-(Dimethylamino)-3,4-dihydroxychalcone ,  4′-(Isopropyloxy)-3,4-dihydroxychalcone ,  2′,4′-Dimethyl-3,4-dihydroxychalcone ,  2′,4′-Dimethoxy-3,4-dihydroxychalcone ,  2′,6′-Dimethoxy-3,4-dihydroxychalcone ,  3′,4′-Dimethoxy-3,4-dihydroxychalcone ,  2′,4′,6′-Trimethyl-3,4-dihydroxychalcone ,  3′,4′,5′-Trimethoxy-3,4-dihydroxychalcone ,  2′,3,4-Trihydroxy-4′-methoxychalcone ,  2′,3,4-Trihydroxy-5′-methoxychalcone ,  3,4,4′-Trihydroxy-3′-methoxychalcone ,  2′,3,4-Trihydroxy-5′-ethoxychalcone ,  2′,3,4-Trihydroxy-5′-isopropylchalcone ,  2′,3,4-Trihydroxy-5′-(isopropyloxy)chalcone ,  2′,3,4-Trihydroxy-5′-butoxychalcone ,  2′,5′-Dimethyl-3,4-dihydroxychalcone ,  2′-Methoxy-3,4-dihydroxy-5′-methylchalcone ,  2′-Methoxy-3,4-dihydroxy-5′-ethoxychalcone ,  2′-Methoxy-3,4-dihydroxy-5′-(isopropyloxy)chalcone ,  2′-Ethoxy-3,4-dihydroxy-5′-methoxychalcone ,  2′,5′-Diethoxy-3,4-dihydroxychalcone

Terms in the title (2)： 5-リポキシゲナーゼ ,  シクロオキシゲナーゼ阻害薬